Development of Vaccines to Prevent Wound Infections Due to Anaerobic Bacteria.
Abstract
Progress on the two major objectives of this contract has been made. The first objective was to bottle and provide safety testing on a Bacteroides fragilis capsular polysaccharide preparation. The antigen was prepared in our laboratory and bottled by the Massachusetts State Public Health Laboratory. The material passed all safety and pyrogenicity studies required by the Food and Drug Administration. The second objective was to study the lymphokine produced by immunization with the polysaccharide. We have shown that a lysate of splenic T cells from animals immunized with the capsular polysaccharide, transfers protection to recipients. The protective material appears to be a lymphokine which is a protein, of small molecular weight. This factor is antigen specific for the immunizing antigen. Keywords: Human hybrido lymphokines; Anaerobic organisms; Laboratory animals.
Document Details
- Document Type
- Technical Report
- Publication Date
- Nov 01, 1984
- Accession Number
- ADA194644
Entities
People
- Dennis L Kasper
Organizations
- Brigham and Women's Hospital